Vancity Investment Management Ltd decreased its position in Danaher Corporation (NYSE:DHR – Free Report) by 4.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 102,773 shares of the conglomerate’s stock after selling 4,437 shares during the quarter. Danaher makes up approximately 3.2% of Vancity Investment Management Ltd’s portfolio, making the stock its 12th largest position. Vancity Investment Management Ltd’s holdings in Danaher were worth $23,526,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in the company. Enterprise Financial Services Corp boosted its stake in shares of Danaher by 1.4% in the 4th quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock worth $737,000 after buying an additional 46 shares during the last quarter. Kennebec Savings Bank increased its position in shares of Danaher by 1.4% during the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock valued at $766,000 after acquiring an additional 46 shares during the last quarter. Revolve Wealth Partners LLC lifted its holdings in Danaher by 2.6% during the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock worth $428,000 after acquiring an additional 47 shares during the period. High Note Wealth LLC boosted its position in Danaher by 19.2% in the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after purchasing an additional 47 shares during the last quarter. Finally, First Command Advisory Services Inc. boosted its position in Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after purchasing an additional 47 shares during the last quarter. 79.05% of the stock is owned by institutional investors.
Danaher Trading Down 0.0%
Shares of Danaher stock opened at $177.74 on Friday. The stock has a market capitalization of $125.80 billion, a P/E ratio of 34.38, a P/E/G ratio of 2.27 and a beta of 0.81. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The stock’s 50-day simple moving average is $179.99 and its 200 day simple moving average is $203.25.
Danaher Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.
Analysts Set New Price Targets
DHR has been the subject of several research analyst reports. Guggenheim decreased their target price on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Royal Bank Of Canada assumed coverage on shares of Danaher in a report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price target on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Finally, Argus dropped their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $233.61.
View Our Latest Research Report on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
